Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative.

Citation: Hammock BD, McReynolds CB, Wagner K, Buckpitt A, Cortes-Puch I, Croston G, Lee KSS, Yang J, Schmidt WK, Hwang SH.: Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative. J Med Chem, Volume 64 (4), 2021
Authors: Buckpitt A, Cortes-Puch I, Croston G, Hammock BD, Hwang SH., Lee KSS, McReynolds CB, Schmidt WK, Wagner K, Yang J
Journal: J Med Chem
Year: 2021
DOI: 10.1021/acs.jmedchem.0c01886
PubMed: 33550801
Machine-readable: REST API RDF

Publication